¹B°Ê¥Í²z¶g°T(²Ä405´Á)
ºC©ÊµÇŦ¯f¤HªºÅé¾A¯à»P¹B°Ê«ü¾É(February 25, 2020)
¤è¶i¶© ¥xÆW®v¤j¦WÅA±Ð±Â
³ü¡B«e¨¥
¡@¡@¥xÆWµÇ¯f¦~³ø (°]¹Îªk¤H°ê®a½Ã¥Í¬ã¨s°|©M¥xÆWµÇŦÂå¾Ç·|¡A2018) «ü¥X¥xÆWµÇŦ¯f¥½´Á¦å²G³zªRµo¥Í²v»P²±¦æ²v¬Ò¥e¥@¬É²Ä¤@¡A¨C¦Ê¸U¤Hªºµo¥Í²v»P²±¦æ²v¤À§O¬°493¤H©M3,392¤H¡A¸Ó¦~³ø2016¦~¸ê®ÆÅã¥Ü¡A¥½´ÁµÇŦ¯f±wªÌ¾ãÅéÂåÀøÂI¼Æ¦û¥þ¥Á°·«O¤ä¥X10.4%¡A¨C¤H¨C¤ë¥§¡Á`ÂåÀøÂI¼Æ¬°6.49-6.71¸UÂI¡A½TÄݬF©²¬Û·íÃe¤jªºÂåÀø¤ä¥X¡C¦p¦ó¦³®Ä°§C¦å²G³zªR¤H¤f¡A¬O¤j®a»Ýn¦@¦PÃöª`ªºÄ³ÃD¡C
¡@¡@¤@¯ë¤Hª¾¹D³W«ß¹B°Ê¹ï°·±d¦³¯q³B¡A¦ý¤£¤Ó¤F¸Ñ¹ïºC©ÊµÇŦ¯f (Chronic Kidney Disease, CKD) ªº«n©Ê¡A¬Æ¦Ü¾á¤ß¦w¥þ¦Ó¯Ê¥F¹B°Ê¡C¡u¹B°Ê´N¬O¨}ÃÄ (Exercise Is Medicine)¡vªº²z©À¤w¸g¦¨¬°°ê»ÚÁͶաA¹ªÀyÂå®v¦b¬°¯f¤H¬Ý¶E®É¡A¯à±N¡y¹B°Ê¡z§@¬°¯e¯fªvÀøªº¤@³¡¥÷¡A¯à¥D°Ê´£¨Ñ¿Ô¸ß©M¹ªÀy¯f¤H°Ñ»P¹B°Ê¡A©ÎÂशµ¹Åé¾A¯à«ü¾Éû©Îª«²zªvÀø®v¡AÅý¯f¤H¯à°÷¤Î¦±q¨Æ¹B°Ê¡C¹L¥h¦³ÃöCKDªº¹B°Ê«ü¾É©Î¬ã¨s³ø¾É¸û¤Ö¡A·|¼vÅT¥Á²³¹B°ÊºA«×¡B»{ª¾©M¦æ¬°¡C
¡@¡@¶V¨Ó¶V¦hªº¬ã¨sÃÒ¹ê³W«ß¹B°Ê¥i¥H§ïµ½±wªÌ¨¤ß°·±d¡B¨Åé¥\¯à©M¥Í¬¡«~½è¡A¦Ó¥B¦b¬ã¨s¤åÄm (Pu et al., 2019) ©Î¬OÂå°|Á{§É¹êÃÒ¡A¬Ò»{¬°¦å²G³zªR¹Lµ{¤¤¹B°Ê¬O¦w¥þªº (Pu et al., 2019; Parker, 2016)¡A¦ý¬O¤j³¡¤ÀCKD¯f¤HÁÙ¬O¯Ê¤Ö¹B°Ê¡AÅé¾A¯à«Ü®t¡A±`±`ı±oµê®z©Î¯h¡C¦p¦ó¤F¸Ñ©M±Æ°£¹B°Ê»Ùê¡A¦Ó±N¨Å鬡°Ê©M¹B°Ê¿Ä¤J¯e¯f¹w¨¾©M§ïµ½¯e¯fªº¤@³¡¥÷¡A±N·|¬O³\¦hÂåÅ@¤Hû¡B¹B°Ê±Ð½m©M¯f¤H®aÄݦ@¦PÃö¤ßªºÄ³ÃD¡C
¡@¡@¥»¤å¥Ñ³W«ß¹B°Ê¡B¨Å鬡°Ê»PÅé¾A¯àªº¨¤«×¡AÂǥѬÛÃö¤åÄmªº¦¬¶°»P¾ã²z¡A±´°Q³W«ß¹B°Ê¹ï©óCKD¯f¤Hªº¯q³B©M¦w¥þ©Ê¡A´£¨Ñ¹B°Ê«ü¾Éì«h©M«ØÄ³¡A¤×¨ä¬O¦å²G³zªR®Éªº¹B°Êª`·N¨Æ¶µ¡A¥H´î¤Ö¹B°Ê¹Lµ{ªº·N¥~¨Æ¥ó¡C¥»¤å¤]´Á±æÁA¸Ñ¯f¤Hªº¹B°Ê»Ùê¡A´£¨Ñ¤@¨Ç¹ê»Ú«ØÄ³©MÀ³¥Î¦æ¬°§ïÅܪkªº²z½×»Pµ¦²¤¡A¨ÓÀ°§U¯f¤H´£¤É¦Û§Ú®Ä¯à¡A¦Ó¯à¹B°Ê¥Í¬¡¤Æ¡A¾i¦¨³W«ß¹B°Ê²ßºD¡C
¶L¡BºC©ÊµÇŦ¯fªº¥\¯à¡B¶¥¬q¡Bª¬ªp»PªvÀø¤èªk
¡@¡@µÇŦªº¥\¯à°£¹LÂo¦å²G¬r¯À©M¨Åé¤ô¤À¥~¡AÁÙ¥]¬A¤Àªc²üº¸»X (¦pµÇ¯À) ½Õ¸`¦åÀ£¡BÄÀ©ñ¬õ¦å²y¥Í¦¨¯À¨ë¿E°©Åè»s³y¬õ¦å²y¡B½Õ¸`¹q¸Ñ½è¥¿Å¡B¦X¦¨ºû¥L©RDºû«ù°©Àf¶t½è©M¨Å饿±`ªº¤Æ¾Ç¥¿Å (½Ã¥ÍºÖ§Q³¡°ê¥Á°·±d¸p¡A2016)¡C
¡@¡@CKD¬OµÇŦµ²ºc»P¥\¯à³vº¥¥¢±`ªº¯e¯f¡A¥xÆWµÇŦÂå¾Ç·| (
http://www.ckd-tsn.org.tw/knowledge/index.php?tab_name=chronic) »{¬°µÇŦ¨ü·l¶W¹L 3Ó¤ë¡A¾ÉP¨äµ²ºc©Î¥\¯àµLªk«ì´_¥¿±`¡AºÙ¬°CKD¡A³q±`¥HµÇµ·²yÂo¹LÈ (GFR) ¨Ó§PÂ_µÇŦ¥\¯à¡A§Y´ú¶q¨C¤ÀÄÁ¦³¦h¤Ö¦å¼ß¸g¥ÑµÇµ·²y¹LÂo¡CCKD¤À¬°¤Ó¶¥¬q¡A³oÓ¹Lµ{¦³ªº¯f¤H«ùÄò«Ü¤[¡A¤]¦³ªº«Ü§Ö´N¶i¤J²Ä¤¶¥¬q¡A§Y¥½´ÁµÇ¯fÅÜ¡An¶i¦æ¦å²G³zªR©Î´«µÇªºªvÀø¡A¦³ÃöCKDªº¶¥¬q¡B¯gª¬©MªvÀø¤èªk¦pªí¤@¡C
ªí¤@¡GºC©ÊµÇŦ¯fªº¶¥¬q¡B¯gª¬»PªvÀø¤è¦¡
| ¶¥¬q | ¯gª¬ | GFR (ml/min/1.73m2) | ªvÀø¤èªk |
| 1 | µÇ¥\¯à¥¿±`¡A¦ý¨Ö¦³³J¥Õ§¿¡B¦å§¿µ¥µÇŦ·l¶Ëª¬ªp | 90~100 | µÇŦ¥\¯à¬ù¥¿±`¤H60%¥H¤W¡Anª`·N¿}§¿¯f¤Î°ª¦åÀ£¤Î±±¨î¦å¿}¡B¦åÀ£»P¶¼¹¡A¨C¥b¦~°µµÇ¥\¯àÀˬd¡A¤@¯ë¬Ò¯àæíµÇ¥\¯à¡CY¦³µÇµ·²yµÇª¢¥²¶·±µ¨üªvÀø¡C |
| 2 | »´«×ºC©ÊµÇ°IºÜ¡A¦ý¨Ö¦³³J¥Õ§¿¡B¦å§¿µ¥ | 60~89 | ¦P¤W |
| 3 | ¤¤«×ºC©ÊµÇ°IºÜ | 30~59 | µÇŦ¥\¯à¬ù¥¿±`¤H15~59%¡A¿n·¥°t¦XÂå®vªvÀø¡A´î½w¶i¤J²Ä¤´Á¥½´ÁµÇ°IºÜ¡C |
| 4 | ««×ºC©ÊµÇ°IºÜ | 15~29 | ¦P¤W |
| 5 | ¥½´ÁµÇŦ¯fÅÜ | ¡Õ15 | µÇŦ¥\¯à¬°¥¿±`¤H15%¥H¤U¡AYµLªk±Æ°£Å餺¥NÁ¼oª«©M¤ô¤À¡A«h¥²¶·³zªR³zªRªvÀø©ÎµÇŦ²¾´Ó¡C |
°Ñ¡BºC©ÊµÇŦ¯f¯f¤Hªº¨Å鬡°Ê¡BÅé¾A¯à»P¦º¤`²v
¡@¡@¤@¯ë¦Ó¨¥¡A¨Åé¹B°Ê¶q¡BÅé¾A¯à (¦p¤ßªÍ¥\¯à©Î¦Ù¦×¾A¯à) »P°·±d¯e¯f¦³¥¿¬ÛÃö¡A§Y¨Å鬡°Ê¶q¶V°ª©ÎÅé¾A¯à¶V¨Î¡A°·±dª¬ªp¶V¨Î¡A¯e¯f¿©±w²v©Î¦º¤`²v´N¶V§C¡C¹L¥h¦³Ãö¨Å鬡°Ê¡BÅé¾A¯à»PCKD¯f¤Hªº°·±dª¬ªp©M¯gª¬¬ã¨s¤£¦h¡A¦³ÃöCKD¯f¤Hªº¨Å鬡°Ê¡BÅé¾A¯à (©Î¨Åé¥\¯à) »P¦º¤`²v©MµÇŦ¥\¯àªºª¬ªp¡B®t²§©Î¬ÛÃö¦p¤U¡G
¤@¡BºC©ÊµÇŦ¯f¯f¤Hªº¨Å鬡°Ê¶q¸û¤Ö
¡@¡@CKD±wªÌ¨Å鬡°Ê¶q¸û¤Ö (Johansen and Painter, 2011)¡AÀHµÛ¯f±¡ªº´c¤Æ¡A¨Å鬡°Ê¶q¶V¨Ó¶V¤Ö (Hellberg, 2018)¡C¬ã¨s«ü¥X¨Å鬡°Ê¸û¦hªºCKD±wªÌ¡A¦º¤`²v©M¯e¯f¥½´Á (²Ä¤¶¥¬q) ¿©±w²v¸û¤Ö (Beddhu, et al., 2009)¡C
¤G¡BºC©ÊµÇŦ¯f±wªÌªºÅé¾A¯à (©Î¨Åé¥\¯à) ¸û®t
¡@¡@Åé¾A¯à»P¨Åé¥\¯à¦³°ª¬ÛÃö¡A¨âªÌ¦³³\¦h¬Ûªñªº¯S½è©Î¯à¤O¡ACKD¯f¤HªºÅé¾A¯à¤ñ¤@¯ë¤H®t¡C¾ÇªÌ (Hellberg, 2018) ¥H101¦ì¥§¡67·³ªº¯f¤H¬°¹ï¶H¡A¥L̪ºµÇµ·²y¹LÂo²v¥§¡¬°22 ml/min/1.73 m2¡A¬ã¨sµo²{¯f¤H¨Åé¥\¯àªº´Á±æÈ¤ñ¤@¯ë¤H§C¡A«O¦s¸û¦nªº¬O¥¿Å¯à¤O(¨Åé«e¦ù¯à¤O)¡A±`¼ÒȬ° (¬Û¹ï¤ñÈ) 96%¡A¨ä¦¸¬O¦Ù¤O¡A¤j»LªÑ¥|ÀY¦Ù¤Oªº±`¼ÒȬ°90%¡A¤â³¡´¤¤O¬°85%¡AµM«á¨Ì§Ç¬O¤ßªÍ@¤O (6¤ÀÄÁ¨«¸ô¶ZÂ÷) ¬ù¬°76%¡A ¦Ù@¤O (30¬í¯¸§¤´úÅç) ¬ù68%¡A³Ì®tªº¬O»·ºÝ¦Ù@¤O (¸}³k¤ÏÂФW©ï¦¸¼Æ)¡A¥ª¥k¸}ªº´Á±æ±`¼ÒȤÀ§O¬°32% ©M 36%¡C
¡@¡@¨ä¥L¬ã¨s¤]«ü¥XCKD¨Åé¥\¯à¸û®t¡A¥§¡¥u¦³¦P¦~Ä֪̪º 60% to 65% (Johansen and Painter, 2011)¡F¬ü°ê¹B°ÊÂå¾Ç·| (ACSM, 2018) «ü¥X²Ä¤¶¥¬qCKD±wªÌªº¨Åé¥\¯à¸û®t¡A¬ù¬°°·±d¦P¦~ÄÖ©M©Ê§OªÌªº50-80%¡A³Ì¤jÄá®ñȬù15-25 ²@¤É/¤½¤ç/¤À¡C
¤T¡B¨Åé¥\¯à (©ÎÅé¾A¯à) »PµÇŦ¯f¦º¤`²v©M¥\¯à¦³¬ÛÃö
¡@¡@Hellberg (2018) ¥H18·³¥H¤W134¦ìCKD¯f¤H¬°¬ã¨s¹ï¶H¡A±´°Q¯f¤Hªº¦º¤`¬O§_»P¨Åé¥\¯à¦³Ãö¡A°Ñ»PªÌ©ó¶}©l¦å²G³zªR«eµû¦ô¨Åé¥\¯à¡A¥]¬A¤â´¤¤O¡B¸}¸ò©ï©ñ¦¸¼Æ (heel rises) ©M¥¿Å¯à¤Oµ¥¸ê®Æ¡AµM«á°lÂÜÆ[¹î¦å²G³zªR«á¯f¤Hªº¦º¤`ª¬ªp¡C¦¹¬ã¨s©ó1998-2006¦~¶i¦æ¡AÆ[¹î®É¶¡¥§¡3.5¦~¡A³o´Á¶¡¦³22¦ì¯f¤H¦º¤`¡A112¦ì¦s¬¡¡A¥H¯f¤H¬O§_¦º¤`¬°¨Ì¾Ú¡A¤À¦¨¦s¬¡»P¦º¤`¨â²Õ¤ñ¸û¨Åé¥\¯à¬O§_¦³®t²§¡Cµ²ªGµo²{¦º¤`²Õªº¨Åé¥\¯àÅãµÛ§C©ó¦s¬¡²Õ¡A¥]¬A¤â´¤¤O¡B¸}¸ò©ï©ñ¦¸¼Æ©M¥¿Å¯à¤O¡C¬ÛÃö¬ã¨s (Hellberg, 2018) ¤]«ü¥X¡G1. ¨S¦³¦å²G³zªR«eCKD±wªÌªº¨Åé¥\¯à»P¦s¬¡²v¦³¬ÛÃö¡C2. ½Õ¾ã¦~ÄÖ¡B©Ê§O©M¦@¯fµ¥Åܶµ«á¡A¤â³¡´¤¤O´î¤Ö50%·|¼W¥[¦º¤`²v¬ù 3¿¡C3. µÇµ·²y¹LÂo²v©M 6 ¤ÀÄÁ¨«¸ô¶ZÂ÷¡BªÑ¥|ÀY¦Ù¦Ù¤O©M¥¿Å¯à¤O¦³ÅãµÛ¬ÛÃö¡C4. µÇµ·²y¹LÂo²v (mGFR) ¨C´î¤Ö10 ml/min/1.73m2¡A6 ¤À¨«¸ô¶ZÂ÷·|´î¤Ö35¤½¤Ø¡AªÑ¥|ÀY¦Ù¦Ù¤O´î¤Ö10%¡C
¸v¡BºC©ÊµÇŦ¯f¯f¤H¹B°Ê°V½m¤è¦¡¡B¯q³B»P¦w¥þ©Ê
¤@¡B¹B°Ê¤¶¤J¤è¦¡¤£¦P·|¼vÅT°V½m®ÄªG
¡@¡@¥Ñ©ó¹L¥h±´°Q¹B°Ê°V½m©Î¤¶¤J¹ï©óCKD¯f¤H¯q³Bªº¬ã¨s«Ü¦h¤¸¡A¦b°V½m¤è¦¡¡BÀW²v¡B±j«×¡B«ùÄò®É¶¡¡B¤¶¤J®É¶¡µ¥¬Ò¦³©Ò¤£¦P¡A¦³ªº¬ã¨s¬OÀH¾÷¤À¬£¸û¬°ÄYÂÔ¡A¦³ªº¬ã¨s¨S¦³±±¨î²Õ¡A¦]¦¹·|³y¦¨¬ã¨sµ²ªGªº®t²§©Î¤£¦P¡C
¡@¡@¹L¥h¬ã¨sªº°V½m¤è¦¡¤j³¡¤À¬O¦³®ñ¹B°Ê¡A¨ä¦¸¬Oªý¤O°V½m©Î¬O¦³®ñ¥[¤Wªý¤Oªº²V¦X°V½m°V½m¡CHellberg (2018) ¾ã²z¤C¤Q½gÀH¾÷¤À¬£ªº¹B°Ê°V½m¬ã¨s¡A³o¨Ç½×¤å±´°Q¹B°Ê¤¶¤J¹ïCKD¯f¤Hªº¼vÅT¡A¨ä¤¤¬ù¦³70%¬ã¨sªº¹B°Ê¤è¦¡¬O¦³®ñ°V½m¡A¨C¶g°V½m3¤Ñ¡A¨C¦¸30-90¤ÀÄÁ¡A¹B°Ê±j«×¬ù¬°³Ì¤jÄá®ñ¶qªº60-80%¡A¨ä¥L30%ªº¬ã¨sªº¹B°Ê¤è¦¡¬°ªý¤O°V½m¡A©Î¬Oªý¤O¥[¤W¦³®ñ¹B°Êªº°V½m¡C¤j³¡¤ÀÀH¾÷¤À¬£¬ã¨sªº°V½m´Á¶¡¬°12¬P´Á¡A¤j³¡¤À (80%) ¬ã¨s´Á¶¡¨S¦³¶W¹L6Ó¤ë¡A¦Ó¶W¹L¤@¦~ªºªø´Á¤¶¤J«Ü¤Ö¡A¬ù¦³10%¡C¨ä¤¤¶W¹L75%ªºÀH¾÷¤À¬£¬ã¨s¹ï¶H¬°¦å²G³zªRªº¯f¤H¡A¤£¬O¦å²G³zªR¯f¤Hªº¬ã¨s¥u¥e21%¥ª¥k (15/70½g)¡A¬Û¹ï¸û¤Ö¡C
¤G¡B¦å²G³zªR¯f¤H±q¨Æ¹B°Ê°V½mªº¯q³B
¡@¡@¾ÇªÌ (Pu et al., 2019) ¥H¤åÄm¦^ÅU©M¾ã¦X¤ÀªR (systematic review and meta-analysis) ¤è¦¡¡A¦¬¶°ÀH¾÷¤À¬£ªº¬ã¨s¡A¥H¤ñ¸û©ó¦å²G³zªR¹Lµ{¤¤¦³¹B°Ê»P¨S¦³¹B°Ê¯f¤Hªº®t²§¡C¾ãÅé°Ñ»PªÌ¦Ü¤Ö¦å²G³zªR 3 Ó¤ë¥H¤W¡A¦Ó¹B°Ê°V½m®É¶¡¦Ü¤Ö«ùÄò 8 Ó¬P´Á¡C¦b 27 ½g¬ã¨s¤¤¡A¦@¦³1215¦ì±wªÌ°Ñ»P¡A¦³ 16 ½g¬ã¨s±Ä¥Î¦³®ñ°VÁå¡A¥t¥~ 4 ½gªº°V½m¤è¦¡¬Oªý¤O°V½m¡A¦Ó¦³ 7 ½g¬ã¨sµ²¦X¦³®ñ¹B°Ê©Mªý¤O°V½m¡A¹B°Ê°V½m´Á¶¡¬° 8-48 ¶g¡C µ²ªG¡G¹B°ÊªÌ¤ñ¨S¦³¹B°ÊªÌ¦b¤U¦C°·±dÅܶµ¦³¹FÅãµÛ®t²§¡G1. ´£¤É³Ì¤jÄá®ñ¶q¡C2. ´î¤Ö¼~Æ{¯g¡C3. §ïµ½¥Í¬¡«~½è¡C4. §ïµ½¤ßÁYÀ£©M¤ßµÎÀ£¡C5. ¼W¥[¦å²G³zªRªº®Ä²v (adequacy)¡A§Y¦b¦å²G³zªR®É¥i¼W¥[¦å²G´`Àô©M±Æ°£§ó¦h¼oª«©M¤ô¤À¡C
¡@¡@¦¹¥~¡A¾ÇªÌ (Parker, 2016) ¾ã²z¹L¥h¤T¤Q¦h¦~¦³Ãö¹B°Ê»P¦å²G³zªRªºÀH¾÷¤À¬£¬ã¨s¡A¥]¬A 6 ½g¨t²Î©Ê¤åÄm¦^ÅU (systematic review) ³ø§i¡A¥H±´°Q¦å²G³zªR¤¤¹B°Ê¹ï¯f¤Hªº¯q³B¡Aµ²ªG°£¤F§ïµ½³Ì¤jÄá®ñ¶q¡Bªq³à¡B¦åÀ£¡B¥Í¬¡«~½è©M¦å²G³zªR®Ä¯q©M¤W½g¬ã¨s¬Û¦P¥~¡A©|¦³¤U¦C¯q³B¡G1. §ïµ½¦åºÞµw¤Æ¡C 2. ¼W¥[¦Ù¤O©M°Ê¤O¡C3. §ïµ½¯h³Òª¬ªp¡C4. §ïµ½ºÎ¯v«~½è¡C5. §ïµ½µoª¢ª¬ªp¡C6. ´î¤Ö¦í°|¡C7. §ïµ½¤£¹ç»L (restless leg) ¯gª¬¡C
¤T¡B¨S¦³¦å²G³zªRµÇŦ¯f¯f¤Hªº¹B°Ê¯q³B
¡@¡@¨S¦³¦å²G³zªRªºCKD¯f¤H¡A¦û±wªÌªº¤j¦h¼Æ¡A¹B°Ê¬O¬Û¹ï¦w¥þªº¡A¤£·|³y¦¨µÇŦ¥\´c¤Æ¡A³o¨Ç¯f¤H§Y¨Ï¨S¦³©úÅã¯gª¬¡A¤´n¤Î¦³W«ß¹B°Ê¡A¥]¬A¦³®ñ¹B°Ê©Mªý¤O°V½m¡A³W«ß¹B°Êªº¥Dn¯q³B¦p¤U¡G1. §ïµ½CKDªº¦@¯f¡G¿}§¿¯f¡B¤ßŦ¯f©M°ª¦åÀ£¬OCKDªº¦MÀI¦]¯À¡A¤]¬O¥Dnªº¦@¯f¡A¦Ó³W«ß¹B°Ê¥i¥H§ïµ½¯Ø®q¯À±Ó·P©Ê©M±±¨î¦å¿}¡A¤]¥i¥H´î§C¤ßÁYÀ£©M¤ßµÎÀ£¡A¤]¯à´£¤É³Ì¤jÄá®ñ¶q¦Ó§ïµ½¤ßŦ¥\¯à©M¯e¯fª¬ªp (U.S. Department of Health and Human Service, 2018; ACSM, 2018; ¤è¶i¶©¡A2019)¡C2. ´î§Cµoª¢«ü¼Ð¡Gµoª¢¬OCKDªº¦MÀI¦]¯À¡A·|¼W¥[¤ß¦åºÞ¯e¯f©M¦åºÞµ°ª¬µw¤Æ¡A³W«ß¹B°Ê¥i¥H´î§CºC©Êªº»´«×µoª¢ (Tyndall, et al., 2018; ¤è¶i¶©¡A2019)¡C3. ´î§C®ñ¤ÆÀ£¤O¡G§C¨Å鬡°Ê¶q©M®ñ¤ÆÀ£¤O¦³Ãö¡A®ñ¤ÆÀ£¤O·|¼W¥[¤ß¦åºÞ¯e¯f©M¦åºÞµ°ª¬µw¤Æ¡A¦Ó³W«ß¹B°Ê¥i¥H´î§C®ñ¤ÆÀ£¤O (Tyndall, et al., 2018; ¤è¶i¶©¡A2019)¡C4. §ïµ½¤ß¦åºÞªº¦MÀI¦]¯À¡G¤ß¦åºÞ¯e¯f¦MÀI¦]¯À»PCKD¦³Ãö¡A³W«ß¹B°Ê°£§ïµ½°ª¦åÀ£¡B¦åÁÞ¥~¡A¤]¯à§ïµ½¦å¯×ªÕ¡B´î§CÅé«©MÅé¯×ªÕµ¥¦MÀI¦]¯À (U.S. Department of Health and Human Service, 2018; ACSM, 2018)¡C5. ¼W¥[¹Ø©R¡GCKD±wªÌªº¹Ø©R¤ñ¤@¯ë¥Á²³µu¡A¤j³¡¤ÀªºµÇŦ¯f±wªÌ¦º©ó¤ß¦åºÞ¯e¯f (Johansen and Painter, 2011, Kendrick, et al., 2019)¡A¦³¥²nÂǥѹB°Ê¨Ó´£¤É¨Åé¥\¯à©M°§C¦@¯f©Ò±a¨Óªº«Â¯Ù¡C 6, ¨ä¥L¡G³W«ß¹B°Ê¥i¥H±a¨Ó³\¦h¯q³B¡A°£¥Í²z®Ä¯q¥~¡A©|¯à§ïµ½¤ß²zÀ£¤O¡B¤H»Ú¤¬°Ê©M¸£³¡°·±dµ¥¡C
¥|¡B ¦å²G³zªR¹Lµ{¹B°Êªº¦w¥þ©Ê
¡@¡@¤@½g¾ã¦X¬ã¨s (Pu et al., 2019) ¤ÀªR 27 ½g¬ã¨s¡A«ü¥X¦b¦å²G³zªR¹Lµ{¤¤¦³¨âÓ§C¦åÀ£·N¥~¨Æ¥ó¡A¤@Óµo¥Í¦b¹B°Ê²Õ¡A¥t¤@Óµo¥Í¦b¨S¦³¹B°Êªº±±¨î²Õ¡C¦¹¥~¡A©Ò¦³¬ã¨s¹Lµ{¦³ 4 ¦¸»P¹B°Ê¦³Ãöªº¤p¨Æ¥ó¡A¦p¥|ªÏ¯kµh©M·L¤p¶Ë®`¡C©Ò¥H¡A¦å²G³zªR¹Lµ{¤¤¡A¦³¹B°ÊªÌ©M¨S¦³¹B°ÊªÌªº·N¥~¨Æ¥óµo¥Í²v¨S¦³®t²§¡A§Y¦å²G³zªR´Á¶¡¹B°Ê¤£·|¼W¥[·N¥~¨Æ¥ó¡C
¡@¡@¦¹¥~¡A¦bÂå°|Á{§É¤W¤]ÃÒ¹ê¦å²G³zªR¹Lµ{¤¤¹B°Ê¬O¦w¥þªº¡A¥[®³¤j·R¦ã§B¹F¬Ù©ó2009¦~¶}©l±À°Ê¦å²G³zªR¹B°Êpµe (The Southern Alberta Renal Program)¡A¤w±q¨Æ 5 ¸U¦¸¥H¤WªºÃM¸}½ñ¨®¹B°Ê¡A¹Lµ{¤¤¨S¦³ÄY«¤ßŦ·N¥~©Î»Ýn¦í°|¨Æ¥ó¡A¥u¬O¤@¨Ç¤pª¬ªp¡A¹³©âµ¬¡B§C¦åÀ£©Î¬O¦Ù¦×»Äµhµ¥ (Parker, 2016 ; Kidney Strategic Clinical Network, Alberta Health Services, 2020)¡C
¥î¡BºC©ÊµÇŦ¯fªº¹B°Ê«ü¾Éì«h
¡@¡@ÁöµM¥Ø«e¨Ã¨S¦³°w¹ïCKD¯f¤H¤@P©Êªº¹B°Ê«ü¾Éì«h¡A¦ý¦³¨Ç³æ¦ì©Î¾÷ºc¨Ì¾Ú¬ã¨sµ²ªG©ÎÁ{§É¸gÅç¡A´£¨Ñ¤@¨Ç«ü¾Éì«h¨Ñ¬ÛÃö¤Hû°Ñ¦Ò¡A¬ü°ê¹B°ÊÂå¾Ç·| (ACSM) ©M¬ÛÃö¾÷ºcªº«ü¾Éì«h¦p¤U¡G
¤@¡B ACSM (2018) ªº¹B°Ê«ü¾Éì«h
¡@¡@ACSM«ØÄ³CKD¯f¤Hªº¹B°Êpµen¥]¬A¦³®ñ¹B°Ê¡Bªý¤O°V½m©M¦ù®i¾Þ¡A¶}©l¹B°Ê®Én¥Ñ§C±j«×©Î¤¤µ¥±j«×¶}©l¡A«ùÄò®É¶¡nµu¡AµM«á¦A¨Ì¾Ú¨CÓ¤Hª¬ªp¡A¦b¯à°÷¾AÀ³©Î§Ô¨üªºµ{«×¡A³vº¥¼W¥[¹B°Ê«ùÄò®É¶¡©M±j«×¡C¦³ÃöCKD±wªÌªº¦³®ñ¹B°Ê¡Bªý¤O°V½m©M¦ù®i¾Þªº«ü¾Éì«h¦p¤U¡G (¤@) ¦³®ñ¹B°Ê¡C1. ¹B°Ê¤è¦¡¡G¦³®ñ¹B°Ê¡A¦p¸}½ñ¨®©Î¨«¸ô¡C2. ÀW²v¡G¨C¶g 3-5¤Ñ¡C3. ¹B°Ê±j«×¡G¤¤µ¥±j«×¡A¹B°Ê¦Ûı¶qªí6-20µ¥¯Åªº12-13¡A©Î40-59%³Ì¤jÄá®ñ¶q©Î¬O³Ì¤j¤ß¸õ²v«O¯dÈ¡A§Y40-59¢H¼¥H (¹w´ú³Ì¤j¤ß¸õ²v´î¥h¦wÀR¤ß¸õ²v) ¡Ï¦wÀR¤ß¸õ²v¡C4. «ùÄò®É¶¡¡G20-60¤ÀÄÁ¡C¦pµLªk«ùÄò§Ô¨ü¡A¨C¦¸¹B°Ê3-5¤ÀÄÁ¡A¤ÏÂЪº¹B°Ê»P¥ð®§¡A²Ö¿n¨ì20-60¤ÀÄÁ¡C(¤G) ªý¤O°V½m¡C1. ÀW²v¡G¨C¶g 2-3¤Ñ¡C 2. ±j«×¡G65-75% 1-RM¡C3. ®É¶¡¡G³Ì¤Ö°µ¤@Ó¦^¦X10-15¦¸¡C¤j³¡¤À¯f¤HÀ³¥i°µ¦hÓ¦^¦X¡C±q¨Æ8-10 Ó¤j¦Ù¦×¸sªº°Ê§@¡C 4. ¤è¦¡¡G¥Î«°V¾÷¾¹¡B¬¡°Ê¾¹§÷ (¦p°×¹a¡A¼u¤O±a) ©Î§Q¥Î¦Û¨Å髵¥¡C(¤T) ¦ù®i¾Þ¡C1. ÀW²v¡G¨C¶g 2-3¤Ñ¡C2. ±j«×¡GÀRºA¦ù®i¨ì¦³ÂIºò©Î»´«×¤£µÎªAµ{«×¡A©Î±Ä¨úPNF (¥»Å鯫¸g¦Ù¦×«P¶i³N) 20-75%³Ì¤j¦Û¥D¦¬ÁY¡C3. ®É¶¡¡G¨CÓÀRºA¦ù®i60¬í (¨CÓ¦ù®i«ùÄò10-30¬í)¡CPNF 3-6¬í¦¬ÁY¡AµM«á 10-30¬íªº³Q°Ê¦ù®i¡C
¤G¡B¨ä¥L³æ¦ìªº«ØÄ³
¡@¡@¥xÆWµÇŦÂå¾Ç·| (http://www.ckd-tsn.org.tw/knowledge/index.php?tab_name=chronic) «ØÄ³±wªÌn§ïµ½¥Í¬¡¶¼¹²ßºD¡A¥]¬A¨C¶g¹B°Ê3¤Ñ¡A¨C¤Ñ¦Ü¤Ö30¤ÀÄÁ¡C¬ü°êµÇŦ°òª÷·| (National Kidney Foundation, 2015 https://www.kidney.org/atoz/content/exercisewyska) «ØÄ³¦p¤@¬q®É¶¡¨S¹B°Ê¡A¶}©l¹B°Ê®É¨C¤Ñ±q¨Æ10-15¤ÀÄÁ¤¤§C±j«×ªº¦³®ñ¹B°Ê (¦p¨«¸ô)¡AµM«áºCºCªº¼W¥[¹B°Ê±j«×¡A¨ì´X¥G¨C¤Ñ¥i¹B°Ê30-60¤ÀÄÁ¡C
¤T¡BÅé¾A¯àÀË´ú»PÀ³ª`·N¨Æ¶µ
¡@¡@ACSM (2018) «ØÄ³Åé¾A¯àÀË´úÀ³ª`·N¤U¦C¨Æ¶µ¡G1. Åé¾A¯àÀË´ú©Î¹B°Ê«e¡An¥h½Ð±Ð°·±d±M·~·ÓÅ@¤Hû (§tÂå®v)¡A¦P·N«á¦A±q¨Æ¹B°Ê©ÎÅé¾A¯àÀË´ú¡C2. Åé¾A¯àÀË´ú©Î¹B°Ê«en¤F¸Ñ¯f¤HªAÃάªp¡G¯f¤H³q±`·|ªA¥Î¦hºØÃĪ«¡A¦pªA¥Î¿}§¿¯f¡B°ª¦åÀ£©M¦å¯×ªÕ²§±`ªºÃĪ«¡A»Ýn®É¥i°µ¾A«×ªº¦]À³¡C3. ¿ï¾Ü°ªÄ֪̪ºÅé¾A¯àÀË´ú¶µ¥Ø¡G¥Ñ©óCKD¯f¤Hªº¨Åé¥\¯à¸û®t¡A¤@¯ë¥Á²³ªºÅé¾A¯à´úÅç¸û¬°¿E¯P¡A¥i¥H¿ï¾Ü°ªÄ֪̩ΰI®z°ªÄ֪̪º¥\¯à©Ê´úÅç¶µ¥Ø¡A¨Óµû¶q¤ßªÍ¥\¯à¡B¦Ù¦×¾A¯à¡B¥¿Å©M¬X³n«×¡C4. ²Ä¤¶¥¬q¦å²G³zªRªº¯f¤H¡A¦b¨S¦³¦å²G³zªRªº®É¶¡±q¨ÆÅé¾A¯àÀË´ú¡C5. ¦pªG±q¨Æ¦Ù¤O´úÅç¡AÁ×§K±q¨Æ³Ì¤j¦Ù¤O´úÅç¡A¦Ò¼{¨Ï¥Î¦Ü¤Ö¤T¦¸ªº«D³Ì¤j¦Ù¤O´úÅç¡A¨Ó¹w´ú³Ì¤j¦Ù¤O¡A¦]¬°³Ì¤j¦Ù¤O´úÅ禳®É·|¦³¦P®É©Ê§è (¼¹) µõ©Ê°©§é¦MÀI (spontaneous avulsion fracture)¡C6. ¦p»Ýn±q¨Æ©T©w¸}½ñ¨®©Î¶]¨B¾÷´ú¶q¨Åé¥\¯à¡A´úÅ窺¤è¦¡nµy¥[×¥¿¡C¥Ñ©ó±wªÌªº¨Åé¥\¯à¸û®t¡A«O¦u»P×¥¿ªº´úÅç¤è¦¡¸û¾A¦X¡C¦p§Q¥Î©T©w¸}½ñ¨®ÀË´ú¡A¶}©l¼ö¨®Éªº¤u§@t²ü¬O20-25¥Ë¡AµM«á¨C1¦Ü3¤ÀÄÁ³vº¥¼W¥[t²ü10-30¥Ë¡C
¥|¡B¹B°Ê°V½m®ÉÀ³ª`·N¤U¦C¨Æ¶µ
¡@¡@ACSM (2018) «ØÄ³¹B°Ê°V½m®ÉÀ³ª`·N¤U¦C¨Æ¶µ¡G1. ºCºC¼W¥[t²ü¡GCKD¯f¤H¡A¥]¬A¦å²G³zªR¯f¤H¡A³£»Ýn¦b¹B°Ê¹Lµ{¤¤³vº¥¼W¥[¹B°Ê¶q¡C¦p¬Y¨Ç¯f¤HµLªk±q¨Æªø®É¶¡ªº¹B°Ê¡A¥i¥H¤À¬q²Ö¿n¹B°Ê«ùÄò®É¶¡¡A¦p¹B°Ê3¤ÀÄÁ¡A¥ð®§3¤ÀÄÁ¡A§Y¥H1:1ªº¹B°Ê»P¥ð®§¤ñ²v¹ê¬I¡C¹B°Ê¾AÀ³«á¡A¨C¦¸«ùÄò®É¶¡¥i¥H¼W¥[¡A¦Ó¥ð®§®É¶¡¥i¥H´î¤Ö¡C¶}©l¹B°Ê®É¡A¦Ò¶q¦Û¤vªºÅé¯à»P°·±dª¬ªp¡A¥i¥H¥Ñ¸ûµuªº®É¶¡ (¦p¨C¦¸15¤À) ¶}©l¡A¦b¥i¥H§Ô¨üªºª¬ªp¤U¡A³vº¥¼W¥[¦Ü³sÄò¹B°Ê20-60¤ÀÄÁ¡C2. ¥ý¼W¥[¹B°Ê«ùÄò®É¶¡¦A´£°ª¹B°Ê±j«×¡G¨Ì¾Ú¨CÓ¤Hªº¯e¯fª¬ªp©M¨Åé¥\¯à¡A¶}©l±j«×n§C¡A®É¶¡nµu¡A¦p¥ý±q¨Æ§C¤¤±j«×¹B°Ê¡A³sÄò¹B°Ê10¦Ü15¤ÀÄÁ¡A©Î¬O±wªÌ¥i¥H§Ô¨üªº®É¶¡¡C·í«ùÄò®É¶¡¥i¥H¶W¹L30¤ÀÄÁ«á¡A¦A¦Ò¶q¼W¥[¹B°Ê±j«×¡C3. §Q¥Î¹B°Ê¦Ûı¶qªí§@¬°¹B°Ê±j«×¨Ì¾Ú¡G¦]¬°¯f¤H¸g±`ªA¥ÎÃĪ«©Î±µ¨ü¦å²G³zªR¡A¥L̪º¹w´Á³Ì¤j¤ß¸õ²v·|¨ü¼vÅT©Î°¾§C¡A©Ò¥H¥Î¹B°Ê¦Ûı¶qªí·í§@¹B°Ê±j«×¸û¾A·í¡C¹B°Ê¦Ûı¶qªíªº§C±j«×¬°9-11¡A¤¤±j«×¬°12-13¤§¶¡½d³ò¡C4. ¦Ò¶q¯f¤Hªº°·±dª¬ªp¡G·í¯f¤Hªº°·±d»PÂåÀøª¬ªp¦³°ÝÃD®É¡A¤£n«j±j¹B°Ê¡A¦³¨Çª¬ªpn°±¤î¹B°Ê©Î´î¤Ö¹B°Êt²ü¡Aº¥¶it²üªº´T«×¤]n´îºC¡C5. ¿ï¾Ü³Ì¨Î¹B°Ê®É¶¡¡G¦å²G³zªR¯f¤H³Ì¦n¦b¨S¦³¶i¦æ³zªR®É¹B°Ê¡A¦p¦b¦å²G³zªR®É¹B°Ê¡A¿ï¾Ü¦b«e¥b¬q («e¨â¤p®É) ¹B°Ê¸û¾A¦X¡A¥iÁ×§K§C¦åÀ£²{¶H¡C¦b¦å²G³zªR§¹¦¨«ánÁ×§K°¨¤W¹B°Ê¡A¥H´î¤Ö§C¦åÀ£·ÀI¡C6. µÇŦ²¾´Ó¯f¤Hªº¹B°Ê¡G¶}¤M«á¸gÂå®v¦P·N«á¡A¥i¥H¶}©l¹B°Ê¡C¦b¦³±Æ¥¸®É´Á¡A¹B°Ê®Én¤p¤ß¡A±j«×n´î§C¡A¦ý¹B°ÊÁÙ¬On«ùÄò¤£n¤¤Â_¡C
³°¡B¥[®³¤jªü§B¶ð¬Ù (Alberta) ªº¦å²G³zªR¹B°Êpµe
¡@¡@¥[®³¤jªü§B¶ð¬Ùªº¦å²G³zªR¹B°Êpµe (Intradialytic Exercise Program at the Southern Alberta Renal Program) ¿n·¥±À°Ê¦h¦~¥B«Ü¦¨¥\ (Parker, 2016)¡C¥Dn¤º®eÂk¯Ç¦p¤U¡G
¤@¡B ±M·~¤Hû¨ó§U±À°Ê
¡@¡@¦b³]¦³¹B°ÊpµeªºCKDÂåÀø³æ¦ì¡A¤u§@¹Î¶¤·|¬ö¿ý±wªÌ¦å²G³zªR®Éªº¹B°Ê®É¶¡¡B¤è¦¡©Mª¬ªp¡A¦³±M¾Åé¾A¯à±M·~¤Hû©Î±Ð½m¨Ót³d°V½m¬ÛÃö¨Æ©y¡A¨Ã³Ð³yÂå°|ªº¹B°Ê¤å¤Æ¡CÅé¾A¯à±Ð½mªºÂ¾³d°£«ü¾É¯f¤H¹B°Ê¥~¡AÁÙn°lÂܩ뜨ô¯f¤H¨C¶g¤@¦¸ªº¹B°Ê¡B°õ¦æ·s¯f¤HªºÅé¾A¯àÀË´ú»P¶^Ë·ÀIµû¦ô¡B¼x¨DÂå®vªº¹B°Ê¦P·N©M¯f¤HÂश¡B¦P¤¯ªº¹B°Ê±À¼sªA°È©M´£¨Ñ´_°·«áªº¹B°Ê³B¤è¡C¦b¦w¥þªºª¬ªp¤U¡A¹B°Ê±M·~¤Hûn¹ªÀy¯f¤H¨C¦¸¦å²G³zªR®É±q¨Æ¸}½ñ¨®¹B°Ê¡C
¤G¡B ±q¨Æ°·±dµû¦ô»P½Õ¬d
¡@¡@²Ä¤@¦¸¨ì¦å²G³zªR¾÷ºc±wªÌn±µ¨ü°·±dµû¦ô¡AÅé¾A¯à±M·~¤Hû¡BÅ@¤h©Îª«²zªvÀø®vt³d§¹¾ãªº°·±dÂåÀøµû¦ô»P½Õ¬d¡A¥]¬A¯e¯f¡BCKDªºì¦]¡BªAÃάªp¡B°©Àf°·±dª¬ªp¡B¤ßŦ©I§l¯gª¬ (¬O§_¯Ý³¡¯kµh¡B©I§l«æ«P©Î¯kµh)¡B¤â³Nª¬ªp¡B¨ü¶Ë¡B¦í°|¡B¶^˸gÅç¡B¹L¥h»P²{¦b¹B°Êª¬ªp©Î²ßºD¡B²{¦b¥Í¬¡ª¬ªp¡B¨Å鬡°Ê¬O§_n»²§U¾¹§÷©M±q¨Æ¤é±`¥Í¬¡ªº¯à¤Oµ¥¡C
¤T¡BÅé¾A¯àµû¦ô
¡@¡@©ó¹B°Ê¶}©l¡B¤@Ó¤ë©M¤»Ó¤ë«á±q¨ÆÅé¾A¯àµû¦ô¡A¥H¤F¸Ñ°Ñ»PªÌ°Ê¾÷©M¹B°Ê°V½m®ÄªG¡C³o¨ÇÅé¾A¯àµû¦ô¥i¦b¦å²G³zªR«eªºµ¥Ô®É¶¡¥[¥H¶i¦æ¡CÅé¾A¯àÀË´ú¿ï¾Ü¦³®Ä«×¥B®e©ö´úÅ窺¶µ¥Ø¡A¥]¬A¡G1. 30¬íªº§¤¯¸´úÅç: ´úÅç¤UªÏ¦Ù¦×¥\¯à¡C 2. ´¤¤O´úÅç¡G¥H´¤¤O¾¹´ú¶q¤WªÏ¦Ù¤O¡C´¤¤O©M¯f¤Hªº¦º¤`²v¦³°ª¬ÛÃö¡C 3. ¥¿Å´úÅç¡G±q¨Æ8^§`ªº¯¸¥ß²¾°Ê´úÅç (8-ft up-and-go) ¥Hµû¶q¥¿Å¯à¤O©M¶^Ë·ÀI¡C30¬íªº§¤¯¸©M8^§`ªº¯¸¥ß²¾°Ê´úÅç¥i°Ñ¦ÒÅé¨|¸pªº°ªÄÖªÌÅé¾A¯àµû¶q¤èªk¡C
¥|¡B¤£¯à¹B°Êªºª¬ªp
¡@¡@±wªÌ¦p¦³¤U¦C¥ô¤@ª¬ªp¡A«h¤£¯à±q¨Æ¹B°Ê¡A©Î»ÝnÂå®v¶i¤@¨Bªºµû¦ô¡C 1. ¤£Ã©wªº¤ßŦª¬ªp (¦p¯Ýµ±µh¡B¥NÀv©Ê¤ß°IºÜ¡B¤£¯à±±¨îªº¤ß«ß¤£¾ãµ¥)¡C2. ¨Å馳¨î©Î»ÙêµLªkÃM©T©w¸}½ñ¨®¡C3. ¦å¿}±±¨î¤£¨Î¡C 4. ¦³·P¬V©Î¥Í¯f¡C5. ¤¤¤ßÀR¯ß¾ÉºÞ©Î°ÊÀR¯ßá½ºÞ /¤H¤u¦X¦¨°ÊÀR¯ß¦åºÞ¥\¯à©Î³sµ²¤£¨Î®É¡C
¤¡B¨C¤Ñ¹B°Ê¦w¥þµû¶q
¡@¡@¥i¥ÑÅ@¤h¡Bª«²zªvÀø®v©ÎÅé¾A¯à«ü¾Éû¥[¥Hµû¶q¡A¨C¦¸¹B°Ê«en½T»{¤U¦C¨Æ¶µ¡G1. ¥Ø¼Ð¹LÂo²v (Targeted ultrafiltration rate)¡G¨C¤p®É¨C¤½¤çÅ髪º¹LÂo²vn¤p©ó13 ²@¤É¡C2. ¦åÀ£±±¨î¡G¦åÀ£À³¤p©ó180/100 ©Î ¤j©ó100/50 mmHg¡C3. ¦wÀR¤ß¸õ²v¤p©ó¨C¤ÀÄÁ100¤U¡C 4. ¤W¶g¨S¦³¦í°|©Î¥Í¯f¡C5. ¤¤¤ßÀR¯ß¾ÉºÞ©Î°ÊÀR¯ßá½ºÞ /¤H¤u¦X¦¨°ÊÀR¯ß¦åºÞ¥\¯à¥¿±`¡C6. ¨S¦³¤£¥¿±`ªº¯gª¬ (¦p·P«_¡BÀYµh¡BÀY·w©Î¹Ã¦Rµ¥)¡C7. ¦å¬õ¯Àn¤j©ó90 g/L or 9 g/dL (¬ü°êµÇŦ°òª÷·|»{¬°²z·Qªº¦å¬õ¯À¬°11 to 12 g /dL; ¦ý¨CÓ¾÷ºc¦³¤£¦Pªº«ØÄ³È)¡C8. ¦å¿}éw (¦b 7 and 14 mmol ©Î126 and 252 mg /dL)¡C9. ¥ð®§®É®ñ¹¡©M«×n°ª©ó90%¡A¦b¹B°Ê¹Lµ{n¶W¹L88%¥B¨S¦³¯gª¬¡C
¤»¡B¹ê¬I¹B°Ê°V½m
¡@¡@°²¨Ï¹F¨ì¤Wz¦w¥þ±ø¥ó¡AÂåÅ@¤Hû·|Â\¸m©T©w¸}½ñ¨®¡AÅý¯f¤H©ó¦å²G³zªRªº«e¨âÓ¤p®É¹B°Ê¡C©Ò¦³·s¯f¤H¶}©l¹B°Ê®É¡An¥H»´ÃPªºt²ü¶i¦æ¡A§Q¥Î§B®æ¹B°Ê¦Ûı¶qªí§PÂ_±j«×¡A¶}©lªº«e¤¦Ü¤Q¤ÀÄÁ¡AÅé¾A¯à±Ð½mnÁ¿¸Ñ¹B°Ê¦w¥þ¡Bº¥¶it²ü©M¾A·í¼ö¨»P½w©Mµ¥¬ÛÃö¨Æ¶µ¡C ¤@¯ë¦Ó¨¥¡A¤£¹ªÀy¯f¤H¦b¹B°Ê¹Lµ{¤¤¥ð®§¡A¦]¬°¥i¯à¼W¥[¦å²G³zªR®Éªº§C¦åÀ£·ÀI¡A©Ò¥H¶}©l¹B°Ê®É«ùÄò®É¶¡nµu¡A¾AÀ³«á¦A³vº¥¼W¥[¹B°Ê®É¶¡¡C
¤C¡Bº¥¶it²ü
¡@¡@°V½m«án³vº¥¼W¥[¹B°Ê®É¶¡¡A¨C¦¸¼W¥[¬ù 2¦Ü 5¤À¡A¤@ª½¨ì¦å²G³zªR®É¶¡¥i¥H¹B°Ê 30¤ÀÄÁ¥H¤W¡A³\¦h¯f¤H¯à°÷«ùÄò¹B°Ê 30¤ÀÄÁ¥H¤W¡C¦b¶}©l 5¤ÀÄÁ»´ÃPªº¹B°Ê«á¡A¹ªÀy¯f¤H±q¨Æ¤¤µ¥¨ì¦³ÂI¿E¯Pªº¹B°Ê±j«×¡A¹B°Êµ²§ô«án¦³ 2¦Ü 5¤ÀÄÁªº½w©M¹B°Ê¡A±j«×µy§C¡C½w©M¹B°ÊÅý¨Å馳¨¬°÷ªº¦å¬y¤À°t¡A¥i¹w¨¾§C¦åÀ£¡C¹B°Ê¹Lµ{ («e¡B¤¤´Á©M«á´Á«á) ¯f¤Hªº¨Å骬ªp·|³Q´ú¶q©Î¸ß°Ý (¦p¤ß¸õ©M¹B°Ê·Pıµ¥)¡C
¤K¡B¹B°Ê¹Lµ{´ú¶q®ñ¹¡©M«×¡A©Ò¦³¯f¤H©ó¹B°Ê«e¡B¤¤©M«á·|´ú¶q®ñ¹¡©M«×¡A¦pªG¬O¿}§¿¯f±wªÌ¡A¹Lµ{¤¤·|´ú¶q¦å¿}¿@«×¡C
¤E¡B¿ï¾Ü¾A¦Xªº©T©w¸}½ñ¨®¡A¨CÓÂåÀø³æ¦ì¬ù¦³¤¡B¤»¥x©T©w¸}½ñ¨® (¦pMonark Rehab Trainer 881E)¡A¦b¸}½ñ¨®©³¤U©ñ¸m·ìÏɹԡA¥H©T©w¹w¨¾·Æ°Ê¡C¸}½ñ¨®®e©ö«O¦s»P¨Ï¥Î¡A¥i¥HÅý¹B°Êpµe®e©ö¶i¦æ¡C¨CÓ³æ¦ì¥i¿ï¾Ü¾A¦Xªº©T©w¸}½ñ¨®¡C
¤Q¡B ªý¤O°V½m©M¦ù®i¾Þ
¡@¡@¦å²G³zªR¹Lµ{¤]¦³¿Ä¤Jªý¤O°V½m©M¦ù®i¾Þ¡AµÇŦ¯fªvÀø³æ¦ì¦³·Ç³Æ¼u¤O±a¡A¥i¥H°µÂ²³æªºªý¤O°V½m¡B¦ù®i¾Þ©M¥¿Å¹B°Ê¡C
¤Q¤@¡B¯S®íª`·N¨Æ¶µ
¡@¡@1. °²¨Ï«e¤@¦¸ªº¦å²G³zªR¨S¦³°µ¡A´N¤£¯à±q¨Æ¹B°Ê°V½m¡A¸¨±¼¤W¦¸ªº¦å²G³zªR·|³y¦¨²GÅé¹L¦hªº¯gª¬¡A¦p©I§l«æ«P¡B¤ô¸~©Î¬O°ª¦å¹[¯g¡C2.¯f¤H¦p¦³°ª¦å¹[¯g©Î§C¦å¹[¯g¡A»Ýn¦Ü¤Ö 30¤ÀÄÁªº¦å²G³zªR«á¤~¶}©l¹B°Ê¡A¥H´î¤Ö«æ©Ê¯gª¬ªº·ÀI¡C3.·s¸Ë¸m°ÊÀR¯ßá½ºÞ /¤H¤u¦X¦¨°ÊÀR¯ß¦åºÞ®É¡A¦å²G³zªR®É¼È®É¤£n¹B°Ê¡Aª½¨ì³sÄò¤T¦¸¦¨¥\ªº¦å²G³zªR«á¤~¶}©l¹B°Ê¡C4.¥Ñ©ó¶¼¤ô¨î¡A¯f¤H¦p¦³¤f´÷·P¡A¹ªÀy¥Ļl¤@ÂI²D¤ô¡A¥H´î¤Ö¤f´÷·P¨Ã´î¤Ö¤ô¤ÀÄá¨ú¡C5.¦å²G³zªR®É¦p·|¦³§C¦åÀ£¡A¹B°Ê«en±±¨î¦åÀ£¡A¹B°Ê«án±q¨Æ¸ûªø®É¶¡ªº½w©M¹B°Ê¡A¥i´î§C³o²{¶H¡C¦¹¥~¡A¹B°Ê«á¯f¤Hªº¸}n°¨¤W©ï°ª¡C 6.¦å²G³zªR®É©âµ¬°ÝÃDÁÙ¨S¦³²`¤J³Q¬ã¨s¡A±wªÌ°¸¦Ó·|¦³©âµ¬²{¶H¡A¦p¦Ù¦×¦å¬y¶q¼W¥[¡A¯f¤Hªº©âµ¬²{¶H·|ÓV¸Ñ¡C¦]¦¹¡A¸û®e©ö©âµ¬ªº¯f¤H¡A¦b¦w¥þªº±¡ªp¤U¡An¹ªÀy±q¨Æ¸}½ñ¨®¹B°Ê¡A¥H´î¤Ö©Î¹w¨¾©âµ¬ªº²{¶H¡C
¬m¡BºC©ÊµÇŦ¯f±wªÌªº¹B°Ê°Ê¾÷©M»Ùê
¡@¡@¦³³\¦h¦]¯À·|¼vÅT¤Hªº¹B°Ê¦æ¬°¡A¥]¬AÓ¤H·Qªk¡B¹B°Ê»{ª¾©MªÀ·|¤ä«ùµ¥¦]¯À¡A¹³ªÀ·|»{ª¾²z½×´N»{¬°¹B°Ê¦æ¬°¬O¨ü¨ìÓ¤H¡B¦æ¬°©MÀô¹Ò¤TÓ¦]¯Àªº¥æ¤¬¼vÅT (¤è¶i¶©¡A2019, ACSM, 2018)¡CÓ¤H¦]¯À (¹³°·±dª¬ªp¡B¹B°ÊºA«×¡B°Ê¾÷µ¥)¡B¦æ¬° (¦p¹B°Ê»{ª¾¡B°Ñ»P©M§Þ¯àµ¥) »PÀô¹Ò (¦p¹B°Ê³õ¦a¡BªÀ·|¤ä«ù©Mªk³W¨î«×µ¥) ¬Ò·|¼vÅT¹B°Ê¦æ¬°¡AnÀ°§U¯f¤H¾i¦¨¹B°Ê²ßºD¡An¥ý¤F¸Ñ¨ä¥Dn¹B°Ê»Ùê©M°Ê¾÷¬O¤°»ò¡HµM«á´£¨Ñ¤@¨Çµ¦²¤©Î¤èªk¨ÓÀ°§U¯f¤H¤Î¦¾i¦¨³W«ß¹B°Ê²ßºD¡C
¤@¡B±wªÌªº¹B°ÊºA«×¡B°Ê¾÷©M»Ùê
¡@¡@¾ÇªÌ (Kendrick et al., 2019) ¥H¨Å鬡°Ê¤£¨¬¡A²Ä¤T©M²Ä¥|¶¥¬qªºCKD±wªÌ¬°¬ã¨s¹ï¶H, °Ý¨÷½Õ±wªÌªº¹B°ÊºA«×¡B°Ê¾÷©M»Ùê¡A¥Dnµ²ªG¦p¤U¡G1. ±wªÌª¾¹D¹B°Ê¹ï°·±dªº¯q³B¡A¦ý¬O¤£ª¾¹D¹B°Ê¹ï©óµÇŦ¯f¯gª¬ªº¦n³B¡C2. ªB¤Í¡B®a¤H©M¹ÎÅé¤ä«ù¡AÁÙ¦³³¯f¤H¹B°Ê¬Ò¯à¼W¥[°Ê¾÷¡C3. ¤j³¡¤À¯f¤Hªí¥ÜÂåÅ@¤Hû«Ü¤Ö´£¨Ñ¹B°Ê»P¯e¯fªº¿Ô¸ß©Î«ØÄ³¡A³o¬O¥L̯ʥF¹B°Êªº»Ùê¡C
¤G¡BÂåÅ@¤Hû´£¨Ñ¹B°Ê¿Ô¸ß»Ppµeªºª¬ªp
¡@¡@¤@Ó¸ó°ê¬ã¨s (Taryana et al., 2019) ½Õ¬dµÇŦ¬ìÂå®v¹ï©ó¹B°Ê¬ÛÃöijÃDªº¬Ýªk¡A¥]¬A³W«ß¹B°Ê¹ï©ó¯f¤H¯q³B¡B¹B°Ê¿Ô¸ß©Î´£¨Ñ¹B°Êpµeµ¥°ÝÃD¡A¥Dnªºµ²ªG¦p¤U¡G1.¤j³¡¤À(90%)µÇŦ¬ìÂå®v»{¬°¹B°Ê¹ï¯f¤H¦³³\¦h¯q³B¡A81%Âå®v¦P·N¹B°Ê¹ï¦å²G³zªR¬ÛÃö¯gª¬¦³À°§U¡A59%Âå®v¦^µª´£¨Ñ¹B°Ê¿Ô¸ß¬OÂåÀø½d³ò (scope of practice) n¬°¯f¤H´£¨Ñ¹B°Ê¿Ô¸ß¡C2.¬ù¦³¥b¼Æ (47%) Âå®v¸g±`©ÎÁ`¬O´£¨Ñ¹B°Ê¿Ô¸ß¡A¦Ó³\¦hÂå®v (42¢H¥[®³¤j¡A¯Ã¦èÄõ»P¿D¬w81%) ¨S¦³´£¨Ñ¹B°Êpµe©Î¸ê·½¡C3.¤j³¡¤À (77%) Âå®v»{¬°¯Ê¥F¸g¶O¬O¨S¦³´£¨Ñ¹B°Êpµe©Î°V½mªº¥Dnì¦]¡C4.¹B°Êpµe©Î°V½mÀ³¥Ñ½Ö¨Ó°õ¦æ¡H 71%Âå®v»{¬°¬O¹B°Ê±Ð½m©Î¬Oª«²zªvÀø®v¡A37%»{¬°¬O®a®xÂå®v¡A53%Âå®v»{¬°¬O¨ä¥LµÇŦ°·±d·ÓÅ@¤Hû¡C5.¦³ 38%Âå®v»{¬°¦³¨¬°÷ÃÒ¾Ú¤ä«ùCKD±wªÌªº³W«ß¹B°Êªº«n¡C¦³35%Âå®v¤£ª¾¹D¦³¤åÄm©Î¬ã¨sÃÒ¾Ú¤ä«ù³W«ß¹B°Ê¹ï©ó±wªÌªº¯q³B¡C
¡@¡@¬ã¨sªÌ»{¬°³æ¦¸¹B°Ê¿Ô¸ß¤£¤Ó¥i¯à§ïÅܱwªÌªº¹B°Ê¦æ¬°¡A»Ýn¤£Â_ªºµ¹¯f¤H¿Ô¸ß¡B¤ä«ù©M¹ªÀy¡A¦]¦¹«ØÄ³¸u½ÐÅé¾A¯à±M·~¤Hû¨Ó¨ó§U±À°Ê¬ÛÃö¹B°Êpµe¡A´£¤É¯f¤Hªº¹B°Ê°Ê¾÷»P¦æ¬°¡C
¡@¡@¥Ñ¤Wz¨âÓ½Õ¬d¬ã¨s¡A·§²¤¥i¤F¸Ñ¥Ø«eµÇŦ¬ìÂå®v¬°¯f¤H´£¨Ñ¹B°Ê¿Ô¸ß©Îpµeªºª¬ªp¡A¤]ª¾¹D±wªÌ¹ï¹B°Ê¿Ô¸ßªº¬Ýªk¡AÅãµMÂåÅ@¤Hûªº¹B°Ê¤ä«ù»P¹ªÀy·|¼vÅT±wªÌªº¹B°Ê¦æ¬°¡C°O±o´X¦~«e¦bºa¥ÁÁ`Âå°|°Ñ¥[¤@ӵǯf¤§¤Í®y½Í·|¡A¥ÑµÇŦ¬ì¥D¥ô¡BµÇŦ¬ìÅ@²z®v©M§Ú¤À§O¥ÑÂåÀø¡B½Ã±Ð©M¹B°Êªº¨¤«×¨Ó³ø§i¤À¨É¡A¨Ã§@¥æ¬y°Q½×¡C·í¤Ñ¡A¤Ñ®ð«Ü§N¡A¤UµÛ¤p«B¡A©Ó¿ìªºÅ@²z®v«Ü¾á¤ß°Ñ¥[¤H¼Æ¤£¦h¡Aµ²ªG¥X®u¤H¼Æ«Ü¿ãÅD¡A¾ãÓºtÁ¿ÆU§¤º¡¯f¤H©M®aÄÝ¡A®y½Í·|«Ü¦¨¥\¡A¬Ò¤jÅw³ß¡C®y½Í·|«á¡A§Ú°Ý¤@¦ì¯f¤H¡A¡u¤Ñ®ð³o»ò§N¡A¬°¤°»ò¤]¨Ó°Ñ¥[¡H¡v¡A¥L¦^µª¡u´N¬O¤U³·¡A§Úª¦³£nª¦¨Ó¡v¡u³o¼Ëªº®y½Í¬O§Ú̳̻Ýnªº¡v¡A³o¦ì±wªÌªº¸Ü°O¾ÐµS·s¡A¤]·P¨ü¨ì¯f¤H¹ï©óCKD¬ÛÃö·ÓÅ@ª¾¯à¤§®ï¤Á»Ý¨D¡C
®Ã¡B«ØÄ³
¡@¡@°ê¤º¥~¤j³¡¤ÀCKD¯f¤H¡A¦]¸û¤ÖÀò¨ú¹B°Ê¬ÛÃö¿Ô¸ß©Î¹ªÀy¡A¦Ó¨S¦³¾i¦¨¹B°Ê²ßºD¡A¾ÉP¨Åé¥\¯à¤£¨Î¡A¨¤ß¶V¨Ó¶V°I®z©M¯h¾Î¡A¬°½T«O¯f¤HÂåÀø¤Î¥Í¬¡«~½è¡A¦ü¥GÀ³§ó¿n·¥±À°Ê¬ÛÃö¤§pµe¡A°£§ë¤J¤H¤O©M¸g¶O¥~¡A¤]n¦³¦h¤¸ªºµ¦²¤°t¦X¡A¥]¬A¬Fµ¦¤ä«ù¡B¸ê°T¤À¨É¡B¹B°Ê¿Ô¸ß»Ppµe¡B¹B°Êª¾¯à©M¹B°Ê¦w¥þºûÅ@µ¥¡A«ØÄ³¦p¤U¡G
¤@¡B¬Fµ¦¤ä«ù
¡@¡@n´î¤Ö¦å²G³zªRªºµo¥Í²v»P²±¦æ²v¡A»Ýn¦b¬Fµ¦»P¸g¶O¤W¤j¤Oªº¤ä«ù¡C¡u¹B°Ê¬O¨}ÃÄ Exercise Is Medicine¡v²z©À¤w³vº¥§Î¦¨ÁͶաA§Æ±æÂåÀø¬Fµ¦¤]°t¦X³o¼é¬y¡A±N¹B°Ê³B¤è©Îpµe¿Ä¤J¯e¯fªvÀøªº¤@³¡¥÷¡A¥]¬A¹ªÀyÂå°|´£¨Ñ¹B°Ê¿Ô¸ß©Mpµe¡A¤ä«ù±q¨Æ¹B°Ê»PºC©ÊµÇŦ¯fªº¬ã¨s»P±À¼s¤u§@µ¥¡C
¤G¡B¸ê°T¤À¨É
¡@¡@¹ªÀy°ê¤ºCKD»P¹B°Ê¬ÛÃöªº¬ã¨s©Î¸ê®Æµoªí¡A¿ì²z¬ÛÃö¬ã°Q·|©Î¤u§@§{¡A´£¨ÑÂåÅ@¤Hû¡BÅé¾A¯à±Ð½m¡B±wªÌ»P®aÄݤF¸Ñ¹B°Ê«O°·ªº¬ÛÃö¸ê°T¡C¹B°Êª¾¯à¤£¨¬¡B¾á¤ß¹B°Ê¦w¥þ©M¤£ª¾¦p¦ó¹B°Êµ¥¦]¯À¡A¬Ò·|¼vÅT¹B°ÊºA«×©M°Ê¾÷¡C
¤T¡B¹B°Ê¿Ô¸ß»Ppµe
¡@¡@§Æ±æ¥¼¨Ó¦³§ó¦hÂåÅ@¤Hû´£¨Ñ¹B°Ê¿Ô¸ß»P¹B°Êpµe¡AÀ°§U¯f¤H¾i¦¨¹B°Ê²ßºD¡CCKD¯f¤H¤j³¡¤À¨Å鬡°Ê¶q¤£¨¬¡A¨Åé¥\¯à¤£¨Î¡An§ïÅܹB°Ê¦æ¬°¡A»Ýnªø®É¶¡µ¹¤©¤ä«ù©M¹ªÀy¡A§ó¦³¿à¾ãÓÂåÀø¹Î¶¤ªº«µø»P¦X§@¡A¹Î¶¤¤¤¸u¥ÎÅé¾A¯à«ü¾Éû¡A¥i³W¹º©M°õ¦æ¦å²G³zªR®Éªº¹B°Êpµe¤]¥i¨ó§U¹B°Ê¿Ô¸ß©M¬ÛÃö¤u§@¡C
¥|¡B¹B°Êª¾¯à
¡@¡@¯f¤Hª¾¹D³W«ß¹B°Ê¹ïCKD¯gª¬©M¨¤ß°·±dªº¯q³B¡A¤]¨ã¦³§ïµ½Åé¾A¯àªº²z©À©M¤èªk¡A´N®e©ö¹B°Ê¥Í¬¡¤Æ¡A¦b®a¸Ì©Î¬O¥Í¬¡¤¤ÀH®É¯à°÷¼W¥[¨Å鬡°Ê¶q¡A¹ï©óÅé¾A¯à©M°·±dª¬ªp´N·|¦³«Ü¤jªº§U¯q¡Cn¯à³W«ß¹B°Ê¤~¯à¯u¥¿ªºÀò±o¯q³B¡A¦Ó¤£¬Oµu®É¶¡ªº¼ö¸Û¡A§Q¥Î¤@¨Ç¦æ¬°§ïÅܪkªºµ¦²¤¡A¹³ªÀ·|¤ä«ù¡A´M§ä®a¤H©ÎªB¤Í¤@°_¹B°Ê¡A¨É¨ü¹B°Ê¹Lµ{¡A¾i¦¨¥¿¦V¹B°ÊºA«×¡C
¤¡Bª`·N¹B°Ê¦w¥þ
¡@¡@ÁöµMCKD¯f¤H©ó¹B°Ê¹Lµ{¤¤¬O¦w¥þ¡A¤Ö¦³¹B°Ê·N¥~¡A¦ý©ó¹B°Ê¹Lµ{¤¤¤@©wnª`·N¦w¥þ¡A¦p¹B°Ê©ÎÅé¾A¯àÀË´ú«e¡An½Ð±ÐÂå®v©Î°·±d±M·~¤Hû¡A¼x¨D¥L̦P·N¨Ã´£¨Ñ·N¨£¡A¦¹¥~¡An¨Ì¾Ú¡u¤£¯kµh¡vªºì«h¡A¹B°Ê®É¦p¨Åé¯kµh©Î¤£µÎªA¡An°±¤î¹B°Ê©Î¬O´î»´¹B°Ê±j«×¡AÅý¯kµh®ø¥¢«á¦A¹B°Ê¡A´N¸û¤£®e©ö³y¦¨¹B°Ê¶Ë®`¡C
¨h ¡Bµ²»y
¡@¡@¨Ì¬ã¨s¤åÄm©MÁ{§É¸gÅç±oª¾¡ACKD¯f¤H¤£½×¬O§_¦å²G³zªR¡A±q¨Æ¹B°Ê³£¬O¦w¥þªº¡A¥un¨Ì¾Ú«ü¾Éì«h©Mª`·N¨Æ¶µ¡A´N¥i¥H´î¤Ö©ÎÁ×§K¹B°Ê¶Ë®`©Î¤£¾A¡C¥Ñ©ó³W«ß¹B°Êªº¼ç¦b®Ä¯q¡A³\¦h¾Ç³N©ÎÂåÀø¾÷ºc¤w´£¨Ñ«ü¾Éì«h¡A«ØÄ³¯f¤Hn¾i¦¨¹B°Ê²ßºD¡A¤]¦³Âå°|¬°¯f¤H³W¹º¹B°Êpµe¡AÀò±oªì¨B¦¨®Ä¡A³o¨Ç¦¨¥\ªº±À¼s²z©À¡B¸gÅç©M¤èªk¡Aȱo§Ṵ́ѦҡC
¡@¡@¡u¹B°Ê´N¬O¨}ÃÄ¡v¡B¡u¹w¨¾«©óªvÀø¡v¡B¡u¦³¹B°Ê¤ñ¨S¹B°Ê¦n¡v©M¡u¦¹B°Ê¤ñ±ß¹B°Ê¦n¡v¡A¬O§Ú¦b¾ã²z³o½g¤å³¹¹Lµ{¤¤¸g±`¯B°_ªº²z©À¡C§Æ±æ¥»¤å¯à©ß¿j¤Þ¥É¿E°_Ãöª`¡A©¹«á¦³§ó¦hªº¤å³¹©Î¬ã¨s¤À¨É¡AÅý§ó¦h¤H¤F¸Ñ¹B°Êªº«n©Ê©M¤èªk¡A¶i¦Ó¿EµoÆF·P¡A´£¥X§ó¦³®Äªºµ¦²¤©Î¿ìªk¡AÅý¯f¤H¯àÀò±o§ó¦hªºª¾¯à¡B¤ä«ù»P¹ªÀy¡A¦Ó±N¹B°Ê¿Ä¤J¥Í¬¡¡A¦Ó¹ï¥Í¬¡«~½è¡B¨Åé¥\¯à©M¯e¯f±±¨î¦³§ó¤jªºÀ°§U¡A¦Ó°§C¦å²G³zªRªº²±¦æ²v»Pµo¥Í²v¡C
¤Þ¥Î¤åÄm
¤è¶i¶© (2019)¡C¹B°Ê³B¤è(¤Gª©)¡C¥x¥_¥«¡GµØ³£¡C
¤è¶i¶© (2019)¡C¨Å鬡°Ê»P¸£³¡°·±d¡C¹B°Ê¥Í²z¶g°T¡A384¡Chttp://www.epsport.net/epsport/week/show.asp?repno=384
°]¹Îªk¤H°ê®a½Ã¥Í¬ã¨s°|©M¥xÆWµÇŦÂå¾Ç·|¡A2018¡A2018¥xÆWµÇ¯f¦~³ø¡C
¥xÆWµÇŦÂå¾Ç·|
http://www.ckd-tsn.org.tw/knowledge/index.php?tab_name=chronic
½Ã¥ÍºÖ§Q³¡°ê¥Á°·±d¸p (2016)¡C
https://www.hpa.gov.tw/Pages/Detail.aspx?nodeid=635&pid=1198
American College of Sports Medicine (2018). ACSM's guidelines for exercise testing and prescription. 10th ed. Philadelphia: Lippincott Williams & Wikins.
Beddhu, S., Baird, B. C., Zitterkoph, J., Neilson, J., & Greene T. (2009). Physical activity and mortality in chronic kidney disease (NHANES III). Clinical Journal American Society of Nephrology, 4, 1901-1906.
Hellberg, M. (2018). Physical Performance and Exercise Training in Patients with Chronic Kidney Disease. Lund University: Faculty of Medicine. https://lup.lub.lu.se/search/publication/15986f79-a663-418d-b049-1213c16b9173
Johansen, K. L. & Painter, P. (2011). Exercise in individuals with CKD. American Journal of Kidney Disease. 59(1), 126-134.
Kendrick, J., Ritchie, M., & Andrews, E. (2019). Exercise in individuals with CKD: a focus group study exploring patient attitudes, motivations, and barriers to exercise. Kidney Medicine, 1(3), 131-138.
Kidney Strategic Clinical Network, Alberta Health Services, Exercise and Chronic Kidney Disease (2020). https://myhealth.alberta.ca/Alberta/Pages/Exercise-and-chronic-kidney-disease.aspx
National Kidney Foundation (2015). https://www.kidney.org/atoz/content/exercisewyska
Parker, K. (2016). Intradialytic exercise is medicine for hemodialysis patients. Current Sports Medicine Reports, 15(4), 269-275.
Pu, J., Jiang, Z., Wu, W., Li, L., Zhang, L., Li, Y., Liu, Q., & Ou, S. (2019). Efficacy and safety of intradialytic exercise in haemodialysis patients: a systematic review and meta-analysis. British Medical Journal Open 2019:9:e020633. doi:10.1136/ bmjopen-2017-020633
Taryana, A. A., Krishnasamy, R., Bohm, C., Palmer, S. C., Wiebe, N., Boudville, N., MacRae, J., Coombers, J. S., Hawley, C., Isbel, N., & Thompson, S. (2019). Physical activity for people with chronic kidney disease: an international survey of nephrologist practice patterns and research priorities. British Medical Journal Open 2019;9:e032322. doi:10.1136/ bmjopen-2019-032322
Tyndall, A.V., Clark, C.M. , Anderson, T. J., Hogan, D. B., Hill, M. D., Longman, R. S., & Poulin, M.J. (2018). Protective effects of exercise on cognition and brain health in older adults. Exercise and Sport Sciences Reviews, 46(4), 215-223.
U.S. Department of Health and Human Service (2018). Physical Activity Guidelines for Americans, 2nd edition. Washington, DC: U.S. Department of Health and Human Service.